https://clinicaltrials.gov/ct2/show/NCT04130997?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Relapsing Multiple Sclerosis (RMS)
Intervention : Biological: Ublituximab
Sponsor : TG Therapeutics, Inc.
Not yet recruiting
An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis
NCT04130997
Fri, 18 Oct 2019 12:00:00 EDT
First Added: 10/18/19 07:26AM